Clinical trial
Assessing the Efficacy of Tranexamic Acid (TXA) in Hip Arthroscopy: A Randomized, Controlled Trial
NCT05710146 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing the Efficacy of Tranexamic Acid (TXA) in Hip Arthroscopy: A Randomized, Controlled Trial
- Lead sponsor
- Northwestern University
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- December 31, 2023
- Completion date
- September 30, 2024
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood loss, femoro acetabular impingement, hip impingement syndrome, hip injuries, hip pain chronic